Showing 4551-4560 of 5623 results for "".
- Heidelberg Engineering Names New Clinical Directorhttps://modernod.com/news/heidelberg-engineering-names-new-clinical-director/2478749/Steve Thomson has joined Heidelberg Engineering as Clinical Director to further strengthen the anterior segment product development team, according to a company news release. He will concentrate
- JPM: BioNTech Hikes COVID-19 Vaccine Output to 2B Doses in 2021—And Plans a Bigger Label, Toohttps://modernod.com/news/jpm-biontech-hikes-covid-19-vaccine-output-to-2b-doses-in-2021-and-plans-a-bigger-label-too/2478746/With its Pfizer-partnered COVID-19 vaccine authorized in the U.S., Europe, the U.K. and a slate of other countries, German mRNA specialist BioNTech is wasting no time scaling up its 2021 pandemic ambitions—namely, 2 billion shots by year-end, plus a slate of new approvals and a temperature-stable
- Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX for the Treatment of Wet AMDhttps://modernod.com/news/clearside-biomedical-announces-first-patients-enrolled-in-phase-1-2a-clinical-trial-of-cls-ax-for-the-treatment-of-wet-amd/2478744/Clearside Biomedical announced that the first patients have been enrolled in its phase 1/2a clinical trial of CLS-AX (axitinib injectable suspension) in patients with wet age-related macular degeneration (AMD). Clinical sites, all based in the United States, are activated and curr
- Aviceda Therapeutics Announces Formation of Executive Teamhttps://modernod.com/news/aviceda-therapeutics-announces-formation-of-executive-team/2478745/Aviceda Therapeutics has announced the composition of the Executive Team that will guide the company through ongoing development of first-in-class therapeutics and continued growth opportunities as a business entity. Aviceda’s lead ophthalmic optimized nanoparticle, as an intravitreal form
- EnChroma Names Vision Industry Veteran Erik Ritchie as CEOhttps://modernod.com/news/enchroma-names-vision-industry-veteran-erik-ritchie-as-ceo/2478743/EnChroma, creators of EnChroma eyewear for color blindness, named Erik Ritchie as its CEO. Mr. Ritchie brings 25 years of experience in the optical industry and other fields. Most recently, he served as Chief Commercial Officer for Zenni Optical, the largest online provider of prescription eyewea
- CorNeat Vision’s First Patient Regains Sight Following Artificial Cornea Implantation at Rabin Medical Centerhttps://modernod.com/news/corneat-visions-first-patient-regains-sight-following-artificial-cornea-implantation-at-rabin-medical-center/2478741/The CorNeat KPro, an artificial cornea that integrates with the eye wall with no reliance on donor tissue, was successfully implanted in a human. The surgery was performed on a bilaterally blind, 78-year-old male at Rabin Medical Center, Israel, by Professor
- EyeSouth Partners Expands Network to Include 28 Doctors in Ohio and Kentucky Through Affiliation with Midwest Eye Centerhttps://modernod.com/news/eyesouth-partners-expands-network-to-include-28-doctors-in-ohio-and-kentucky-through-affiliation-with-midwest-eye-center/2478742/EyeSouth Partners has announced that it has completed an affiliation with Midwest Eye Center (MWEC), representing EyeSouth’s first in the states of Ohio and Kentucky. Terms of the deal were not disclosed. Midwest Eye Center is led by Drs. Mark Cepela, Jean Noll, Faiz Khaja, Saif Jaw
- Biden Aims to Release All Available COVID-19 Vaccine Doses to Speed Up Distribution: Reporthttps://modernod.com/news/biden-aims-to-release-all-available-covid-19-vaccine-doses-to-speed-up-distribution-report/2478739/President-elect Joe Biden will seek to release nearly every available dose of the coronavirus vaccine when he takes office later this month, a move that signals a departure from the Trump administration and the FDA’s current stance of holding back half of the US vaccine supply in order to e
- Bayer Strikes Alliance to Advance CureVac’s COVID-19 Vaccine CVnCoVhttps://modernod.com/news/bayer-strikes-alliance-to-advance-curevacs-covid-19-vaccine-cvncov/2478735/Bayer said that it has reached an agreement to further the development, supply and key territory operations of CureVac’s COVID-19 vaccine candidate CVnCoV. The companies indicated that they plan to combine their strengths for CureVac to be in a position to supply “hundreds of millions
- Moderna’s COVID-19 Vaccine Becomes Second to Nab EU Authorizationhttps://modernod.com/news/modernas-covid-19-vaccine-becomes-second-to-nab-eu-authorization/2478725/The European Commission on Wednesday granted a conditional marketing authorization for Moderna’s COVID‑19 vaccine mRNA-1273, making it the second coronavirus vaccine authorized in the EU. The decision comes hours after the European Medicines Agency (EMA) had recommended authorizing mRNA-127